[The clinical efficacy of roxithromycin in patients with acute odontogenic infections].
The clinical efficacy of a macrolide antibiotic, roxithromycin, was evaluated in 24 patients affected by acute odontogenic infections. Patients were treated with a first dose of 300 mg p.o. which was followed by 150 mg p.o. 12-hourly for the following two days. Total responses were evaluated by an arbitrary scale. The results showed that an excellent and good response was obtained in 99.96% of treated patients. On the basis of clinically compared data and the drug safety it may be concluded that roxithromycin can be successfully used in the treatment of odontogenic infections.
Panattoni
E
E
Istituto di Clinica Odontoiatrica, Università degli Studi di Pisa.
Marcucci
M
M
Gabriele
M
M
Natale
M L
ML
Blandizzi
C
C
Bernardini
N
N
Del Tacca
M
M
D000208:Acute Disease; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D005491:Focal Infection, Dental / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010482:Periapical Abscess / Q000188:drug therapy; D011842:Radicular Cyst / Q000188:drug therapy; D012074:Remission Induction; D015575:Roxithromycin / Q000627:therapeutic use*; D013997:Time Factors
D015575:Roxithromycin
Efficacia clinica della roxitromicina in pazienti affetti da infezioni odontogene acute.